Cite
HARVARD Citation
Somlyay, M. et al. (n.d.). Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling. European journal of cancer. pp. S44-S45. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Somlyay, M. et al. (n.d.). Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling. European journal of cancer. pp. S44-S45. [Online].